Category Archives: Complications

Trocar Chest Tubes Or Blunt Technique? Part 2

In my last post on chest tube insertion technique, I reviewed a paper that compared chest tube insertion complications using two different trocar tips, blunt plastic and sharp metal. The sharp tip tubes caused more complications, although the study was weakened by the fact that the physicians inserting the tubes were complete newbies.

Today, I’ll discuss what the authors call a “best evidence topic” that reviewed the safety of the trocar technique. It is similar to a meta-analysis of available literature that attempts to reach a conclusion regarding this type of tube insertion. A literature search from 1946 to 2013 was conducted seeking to pull all papers on trocar chest tube insertion techniqes. A total of 258 papers were identified, but on closer inspection only 7 were identified that “provided the best evidence to answer the question.”

Here are the factoids from some of these papers:

  • Tube malposition occurred significantly more often in a series of 106 trocar tubes inserted into 75 ICU patients
  • In trocar tubes inserted for trauma, CT showed malplacement in 29% vs 19% with non-trocar tubes [This latter number seems very high to me!]
  • A retrospective study of 1249 patients resulted in the trocar technique being abandoned due to severe lung and stomach injuries
  • Use of trocar technique was associated with a significantly higher incidence of re-expansion pulmonary edema in 92 patients with spontaneous pneumothorax
  • A poorly controlled prospective study showed 23 complications with trocar technique and none with blunt dissection. The denominator could not be determined.

Bottom line: Overall, the literature is just not good enough to answer this question. But it does provide some suggestions.

  • Trocar insertion can be done well in experienced hands. Cardiac surgeons use these all the time, although sometimes they have the benefit of already being in the chest so they can visualize the point of entry and control the tip.
  • Any chest tube insertion can go awry.  It’s very important to learn proper technique, and take care to apply it faithfully, even in emergency situations.
  • If you really like trocars and want to improve insertion safety, start with the blunt dissection technique first, sweep a finger inside the chest to ensure there are no adhesions, then insert the trocar tube to guide it into position. Please note that I do not believe that we can control the tube once the instrument (trocar or clamp) are removed from the chest. And the tube will work fine just about anywhere it ends up (unless that’s the spleen).
  • Newbies should be supervised carefully and learn blunt insertion technique first. Be mindful that it is still possible to pass the insertion clamp into the same structures as a trocar if you are not careful. My practice is to place my fingers about 2 cm from the tip of the clamp as I push it through the pleura. If the pleura gives way more easily than anticipated, by fingers will keep the clamp from going too far into the chest. 
  • Always mark your insertion spot before prepping. This will generally be lateral to the nipple in men, so always prep the nipple into your field as a landmark.
  • Always be careful!

Reference: Is the trocar technique for tube thoracostomy safe in the current era? Interactive CV and thoracic surg 19:125-128, 2014.

Print Friendly, PDF & Email

Trocar Chest Tubes Or Blunt Technique? Part 1

This is an old question: what is the best way to insert a chest tube? There are several techniques available to us:

  • Blunt dissection and insertion
  • Trocar with a blunt tip (plastic stylet)
  • Trocar with a sharp tip (metal stylet)
  • Seldinger technique for small tubes

Typically, when there are multiple ways to do a thing, then there is no clear choice as to which is better. It then becomes a personal choice, or one driven by the financial considerations of the equipment used, and demonstrates the need for a practice guideline.

There are very few good papers out there that critically compare any of these techniques. Today, I’ll review one cadaver study and tomorrow I’ll tackle one “best evidence” paper that attempt to answer it.

A group in Vienna, Austria performed a cadaver study comparing the use of the two types of trocar tubes:

The top tube is the sharp trocar type, the bottom is the blunt trocar.

The study engaged twenty emergency medicine residents who had little, if any, experience placing chest tubes. Each placed 10 chest tubes (5 of each type) in fresh cadavers after undergoing a one-hour standardized lecture on anatomy, technique, and complications. The authors tabulated insertion times, as well as complication and success rate based on anatomic dissection.

Tube type was randomly assigned for each attempt by each resident. One blunt insertion and one sharp insertion were performed on opposite sides of a cadaver each month for the trainees. Over a period of 5 months, each resident performed 10 total insertions.

Here are the factoids:

  • Mean time to insertion for blunt vs sharp tips was the same, about 60 seconds
  • Insertion time declined by about 20 seconds by the final attempt at 5 months
  • Accurate placement occurred in 94% of blunt tip tubes vs 86% of sharp tip tubes
  • There were significantly more complications with the sharp tip (4 below diaphragm, 5 outside the thorax, 1 in the liver,  and 4 in the spleen) vs the blunt tip (2 below diaphragm, 2 extrathoracic, 2 in the liver, and 2 aborted due to damage to the tube)
  • BMI did not increase complications, but it did increase insertion time significantly

The authors concluded that there is a 6-14% complication rate that is operator related, and that the incidence of complications was increased with the use of a sharp tip tube. They warn against the use of these tubes.

Bottom line: This is certainly an interesting study. The insertion numbers are sort of reasonable, and the use of fresh cadavers is okay. They are not quite as realistic as real living people, but close. The biggest drawback was that they used chest tube newbies, most of whom had never inserted a tube. And they were placed in the unrealistic setting where they had to attend training and watch a video, then insert two tubes per month without coaching or supervision. This is not how we do it in the real world. 

I was impressed with what I consider the high number of complications. I don’t typically see that many, although I work at a blunt dissection institution. However, it does show that any trocar style tube is probably more like a weapon in inexperienced hands. So perhaps, even with supervision, both sharp and blunt trocar types should be avoided in the teaching setting. Sure, blunt dissection may take a bit longer, but the tube is also less likely to end up somewhere it shouldn’t be.

Tomorrow: Review of a “best evidence” review from New York.

Reference: Evaluation of performance of two different chest tubes with either a sharp or a blunt tip for thoracostomy in 100 human cadavers. Scand J Trauma Resus Emerg Med 20:10, 2012.

Print Friendly, PDF & Email

Retained Hemothorax: The Practice Guideline

Over the last few days, I’ve reviewed some data on managing hemothorax, as well as the use of lytics. Then I looked at a paper describing one institution’s experience dealing with retained hemothorax, including the use of VATS. But there really isn’t much out there on how to roll all this together.

Until now. The trauma group at Vanderbilt published a paper describing their experience with a home-grown practice guideline for managing retained hemothorax.  Here’s what it looks like:

I know it’s small, so just click it to download a pdf copy. I’ve simplified the flow a little as well.

All stable patients with hemothorax admitted to the trauma service were included over a 2.5 year period. The practice guideline was implemented midway through this study period. Before implementation, patients were treated at the discretion of the surgeon. Afterwards, the practice guideline was followed.

Here are the factoids:

  • There were an equal number of patients pre- and post-guideline implementation (326 vs 316)
  • An equal proportion of each group required an initial intervention, generally a chest tube (69% vs 65%)
  • The number of patients requiring an additional intervention (chest tube, VATS, lytics, etc) decreased significantly from 15% to 9%
  • Empyema rate was unchanged at 2.5%
  • Use of VATS decreased significantly from 8% to 3%
  • Use of catheter guided drainage increased significantly from 0.6% to 3%
  • Hospital length of stay was the same, ranging from 4 to 11 days (much shorter than the lytics studies!)

Bottom line: This is how design of practice guidelines is supposed to work. Identify a problem, typically a clinical issue with a large amount of provider care variability. Look at the literature. In general, find it of little help. Design a practical guideline that covers the major issues. Implement, monitor, and analyze. Tweak as necessary based on lessons learned. If you wait for the definitive study to guide you, you’ll be waiting for a long time.

This study did not significantly change outcomes like hospital stay or complications. But it did decrease the number of more invasive procedures and decreased variability of care, with the attendant benefits from both of these. It also dictates more selective (and intelligent) use of additional tubes, catheters, and lytics. 

I like this so much that I’ve incorporated parts of it into the chest tube guideline at my center!

Download the practice guideline here.

Related posts:

Reference: Use of an evidence-based algorithm for patients with traumatic hemothorax reduces need for additional interventions. J Trauma 82(4):728-732, 2017.

Print Friendly, PDF & Email

Surgical Management Of Retained Hemothorax – VATS

I’ve written about the use of lytics to treat retained hemothorax over the past few days. Although it sounds like a good idea, we just don’t know that it works very well. And they certainly don’t work fast. Lengths of stay were on the order of two weeks in both studies reviewed.

The alternative is video assisted thoracoscopic surgery (VATS). So let’s take a look at what we know about it. This procedure is basically laparoscopy of the chest. A camera is inserted, and other ports are added to allow insertion of instruments to suck, peel, and scrape out the hemothorax.

A prospective, multi-center study was performed over a 2 year period starting in 2009. Twenty centers participated, contributing data on 328 patients with retained hemothorax. This was defined as CT confirmation of retained blood and clot after chest tube placement, with evidence of pleural thickening.

Here are the factoids:

  • 41% of patients had antibiotics given for chest tube placement (this is interesting given the lack of consensus regarding their effectiveness!)
  • A third of patients were initially managed with observation, and most of them (82%) did not need any further procedures (83 of 101 patients)
  • Observation was more successful in patients who were older, had smaller hemothoraces (<300cc), smaller chest tubes (!!, <34 Fr), blunt trauma, and peri-procedure antibiotics (?)
  • An additional chest tube was inserted in 19% of patients, image guided drain placement in 5%, and lytics in 5%. Half to two-thirds of these patients required additional management.
  • VATS was used in 34% of patients. One third of them required additional management including another chest tube, another VATS, or even thoracotomy.
  • Thoracotomy was most likely required if there was a diaphragm injury or large hemothorax (<900cc)
  • Empyema and pneumonia were common (27% and 20%, respectively)

Bottom line: There’s a lot of data in this paper. Most notably, many patients resolve their hemothorax without any additional management. But if they don’t, additional tubes, guided drain placement, and lytics work only a third of the time and contribute to additional time in the hospital. Even VATS and thoracotomy require additional maneuvers 20-30% of the time. And infectious complications are common. This is a tough problem!

Tomorrow, I’ll try to roll it all together and suggest an algorithm to try to optimize both outcomes and cost.

Reference: Management of post-traumatic retained hemothorax: A prospective, observational, multicenter AAST study. 72(1):11-24, 2012.

Print Friendly, PDF & Email

Retained Hemothorax Part 2: Lytics (again)

Yesterday, I reviewed a small case report that was published a couple of years ago on lytics for treatment of retained hemothorax. But surely, there must be something better, right?

After digging around, I did find a paper from 2007 that prospectively looked at protocolized management of retained hemothorax, and its aftermath. It was carried out at a busy Level I trauma center over a 16 month period.

All patients with a hemothorax treated with chest tube received daily chest x-rays. Those with significant opacification on day 3 underwent CT scan of the chest. If more than 300 cc of retained blood was present, the patient received streptokinase or urokinase (surgeon preference and drug availability) daily, and rolled around in bed for 4 hours to attempt to distribute it. The chest tube was then unclamped and allowed to drain. This was repeated for 3 days, and if there was still opacification, a repeat CT was obtained. If the volume was still greater than 300 cc, the cycle was repeated for the next 3 days. If the opacification cleared at any point, or the repeat CT showed less than 300 cc, the protocol was stopped and the chest tube removed. If the chest was still opacified after 6 days, VATS was offered.

Here are the factoids:

  • A total of 203 patients with hemothorax were admitted during the study period and 25 (12%) developed a retained hemothorax
  • While a few had treatment start within 4 days, the majority did not receive lytics until day 9 (range 3  –30 days!)
  • The average length of time in hospital after start of lytics was 7 days, leading to a total length of stay of 18 days
  • 92% of patients had “effective” evacuation of their retained hemothorax, although 1 had VATS anyway which found only 100 cc of fluid
  • 16 patients had “complete” evacuation, and 5 had “partial” evacuation
  • There were no hemorrhagic complications, but one third of patients reported significant pain with drug administration

Bottom line: Sounds good, right? The drug seems reasonably effective, although lengths of stay are relatively long. However, streptokinase and urokinase are no longer available in the US, having been replaced with tissue plasminogen activator (tPA). This paper does a cost analysis of lytics vs VATS and found that the former treatment cost about $15000 (drug + hospital stay) vs $34000 for VATS. However, a big part of this was that the drug only cost about $75 per dose. tPA is much more expensive.

So once again, small series, longer lengths of stay, but at least nicely done. Unfortunately, the drug choice is no longer available so use of tPA tilts the balance away from lytics. 

Reference: Intrapleural Thrombolysis for the Management of Undrained Traumatic Hemothorax: A Prospective Observational Study. J Trauma 62(5):1175-1179, 2007.

Print Friendly, PDF & Email